Liquidia Corporation Common Stock vs Otis Worldwide Corp — how do they compare? Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B), while Otis Worldwide Corp trades at $69.73 (market cap $26.31B). The key difference: Otis Worldwide Corp is far larger — about 8.7× Liquidia Corporation Common Stock's market cap, and Otis Worldwide Corp pays a 2.55% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Otis Worldwide Corp for 66 Days on average.
| LQDA | OTIS | |
|---|---|---|
Market Cap | $3.04B | $26.31B |
Volume | 21,111,778 | 4,760,505 |
Sector | Health | Industrials |
52-Week High | $91.03 | $93.62 |
52-Week Low | $22.02 | $64.05 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $2.94B | $34.34B |
Dividend Yield | — | 2.55% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Otis Worldwide trades at $67.68, up 1.39% today but near its 52-week low amid bearish technical signals and recent earnings misses. The company maintains stable revenue around $14.4B with a net margin of 10.17%, but faces margin pressure and negative shareholder equity. Analyst consensus is mixed with a $87 price target, while news highlights CEO succession plans and China market challenges.
The stock offers a potential upside based on analyst targets, but risks include persistent margin compression, high debt levels, and weak equipment demand. Service segment growth and modernization backlogs provide stability, yet investor sentiment remains cautious pending clearer margin recovery and leadership transition execution in 2027.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →